Calidi Biotherapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

10.68M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	45.00K	-404.00K	-89.98%
Dec 31, 2021	449.00K	-	-
Dec 31, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	435.16B
Johnson & Johnson	92.15B
Merck & Co.	64.24B
AbbVie	59.64B
Eli Lilly and Company	59.42B
AstraZeneca	58.13B
Novartis AG	56.37B
Novo Nordisk	49.58B

Revenue Rankings

CLDI News

18 days ago - Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025 - GlobeNewsWire
22 days ago - Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewsWire
3 months ago - Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option - GlobeNewsWire
3 months ago - Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering - GlobeNewsWire
4 months ago - Calidi Loss Down 23 Percent in Fiscal Q2 - The Motley Fool
4 months ago - Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewsWire
4 months ago - Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025 - GlobeNewsWire
4 months ago - Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24 - GlobeNewsWire

More News